astrazeneca oral glp 1 drug AstraZeneca's obesity Elecoglipron has advanced to Phase III clinical trials after AstraZeneca obesity pill helps patients

People experiencing significant fatigue on GLP-1 medications who have already addressed basic factors like hydration, protein intake, and electrolytes may find that levocarnitine helps by improving mitochondrial energy production from fat stores

Prediabetes is associated with an increased risk of cardiovascular disease

First, the molecular trigger specificity of oxalate-induced ferroptosis in renal tubular cells is undefinedhow oxalate precisely initiates the synergistic dysregulation of iron uptake (TFR1), lipid metabolism (ACSL4), and antioxidant defense (GPX4/SLC7A11) remains elusive, with no clarity on upstream signaling molecules or post-translational modifications that link oxalate exposure to ferroptosis machinery

Bibliography DailyMed/FDA labeling